KEGG: spo:SPCC645.02
STRING: 4896.SPCC645.02.1
G-quadruplexes (G4s) are non-canonical nucleic acid structures formed by guanine-rich sequences. These structures arise when four guanine bases arrange in a square planar configuration through Hoogsteen hydrogen bonding to form G-tetrads, which can stack to create G4 structures. They play critical roles in gene regulation, chromosome fragility, and telomere maintenance . Their significance extends to various cellular processes including DNA replication, transcription, and repair mechanisms, making them important targets for genomic research .
BG4 is a highly specific monoclonal antibody developed to target DNA G-quadruplex structures. It's a single-chain variable fragment (scFv) construct that is FLAG-tagged . Unlike other G4-binding molecules that may interact with various DNA structures, BG4 demonstrates robust specificity for G4 DNA forms with a binding affinity (Kd) of 17.4 nM as revealed by bio-layer interferometry (BLI) studies . BG4 specifically binds to G-rich DNA sequences that form G-quadruplexes but not to complementary C-rich or random sequences . This high specificity makes it particularly valuable for research applications requiring precise G4 detection.
BG4 exhibits differential binding specificity based on G4 conformation. Gel shift assays demonstrate that BG4 preferentially binds to G4-DNA in parallel orientation, whether in inter- or intramolecular forms . Importantly, the mere presence of a G4-motif within duplex DNA is insufficient for antibody recognition, indicating that the actual formation of the G4 structure is necessary for BG4 binding . This structural specificity allows researchers to distinguish between different G4 conformations within cellular contexts.
G4 antibodies, particularly BG4, have revolutionized our understanding of the G4 landscape through G4-chromatin immunoprecipitation (G4-ChIP) techniques. Traditional G4-ChIP methods have been shown to preferentially report G4s that become crosslinked to nearby proteins, potentially biasing against transient G4s that aren't stabilized by protein binding . Recent methodological improvements enable capturing G4s more efficiently without this bias, while also eliminating the detection of G4s formed artifactually on crosslinked sheared chromatin post-fixation . These advanced approaches have revealed new insights, such as G4s forming sparingly at SINEs (Short Interspersed Nuclear Elements) and relationships between G4 formation and regions of sharp interstrand G/C-skew transitions .
Research using BG4 has demonstrated that G4-DNA exists intracellularly and interacts with various proteins that can either stabilize or resolve these structures. For instance, knockdown of the G4-resolvase WRN (Werner syndrome ATP-dependent helicase) modulates the number of BG4 foci within cells, indicating dynamic regulation of G4 formation and resolution . Additionally, depletion of the repeat-binding protein CGGBP1 enhances G4 capture at CGGBP1-dependent CTCF-binding sites . These protein-G4 interactions have significant implications for genomic stability, as unresolved G4 structures can lead to replication stress and genomic instability. Understanding these interactions provides insights into potential therapeutic targets for diseases associated with genomic instability.
Current G4 detection methods face several challenges. Traditional in vitro techniques may not accurately reflect the cellular environment where G4 formation occurs. The conventional understanding that G4 formation depends on G-repeats forming tetrads has been challenged by genome-wide sequencing data suggesting G4 formation at regions lacking canonical G4-forming signatures . Additionally, our understanding of protein-bound versus free G4s remains limited. Recent methodological improvements address these limitations by developing protocols that capture G4s efficiently without bias toward protein-bound structures . Another advancement is the development of SG4, a camelid heavy-chain-only derived nanobody with low nanomolar affinity for various folded G4 structures, offering an alternative to BG4 for certain applications .
For immunofluorescence studies, BG4 applications require specific optimization to ensure sensitive and specific detection of G4 structures. The protocol typically involves:
Cell fixation with paraformaldehyde (PFA) to preserve cellular architecture
Permeabilization with Triton X-100 to allow antibody access
Blocking with BSA to reduce non-specific binding
Primary incubation with BG4 antibody (typically at 4μg/ml concentration)
Secondary detection using anti-FLAG antibodies (since BG4 is FLAG-tagged)
Tertiary detection with fluorescently labeled antibodies
Counterstaining for DNA (DAPI) and cellular structures as needed
This multi-step detection approach allows visualization of G4 foci within cellular contexts, enabling studies on their distribution and abundance in different cell types and under various conditions . Example studies have demonstrated successful BG4 foci detection across various cell lines, irrespective of their lineage, confirming the presence of G4-DNA in the genome .
For laboratories wishing to produce their own BG4, the plasmid is commercially available through Addgene (plasmid #55756) . The expression and purification protocol typically involves:
Transformation of the plasmid into an appropriate E. coli strain
Induction of protein expression using IPTG
Cell lysis to release the expressed protein
Purification using affinity chromatography (leveraging the FLAG tag)
Quality control testing for binding specificity
Detailed procedures for BG4 expression and purification are available from the Balasubramanian laboratory, which developed the antibody . Researchers should be cautious about using alternative BG4 derivatives with different tags, as these may not perform identically to the original construct .
G4-ChIP experiments require careful attention to several methodological aspects:
Fixation conditions: Overfixation can create artifacts while underfixation may miss transient G4s
Chromatin shearing: Optimal fragment size is crucial for specificity and resolution
Antibody specificity: BG4 shows high specificity but requires optimized conditions
Controls: Include both positive (known G4-forming regions) and negative controls
Bias mitigation: Be aware that traditional G4-ChIP methods may preferentially detect protein-associated G4s
Cross-validation: Combine with complementary techniques like in vitro G4 formation assays
Recent methodological improvements have addressed several biases in G4-ChIP, particularly the preferential detection of G4s crosslinked to nearby proteins versus transient G4s not stabilized by protein binding . Researchers should consider these factors when designing G4-ChIP experiments and interpreting their results.
Distinguishing genuine G4 structures from artifacts requires multiple validation approaches:
Multiple detection methods: Combine G4-ChIP with orthogonal techniques such as computational prediction, chemical mapping, and in vitro formation assays
Sequence validation: Confirm that identified regions contain canonical G4-forming sequences or validate non-canonical sequences through structural studies
G4-stabilizing compounds: Test if G4-stabilizing ligands increase signal at putative G4 sites
G4-resolving helicases: Determine if overexpression of G4-resolving proteins (like WRN) reduces signal
Negative controls: Include regions known not to form G4s in analyses
Artifactual G4 formation: Be aware that shearing and processing can create conditions favoring artificial G4 formation in G-rich regions
Recent advances in methodology have specifically addressed the elimination of G4s formed artifactually on crosslinked sheared chromatin post-fixation, providing more reliable detection of genuine cellular G4 structures .
Multiple factors affect G4 formation and stability within cells:
Understanding these factors is crucial for interpreting experimental results and designing studies that accurately reflect cellular G4 dynamics.
G4 research occasionally produces seemingly contradictory findings, which can be reconciled through:
Methodological differences: Different detection methods may have distinct biases and sensitivities
Cellular context variations: G4 formation can be cell-type and condition-specific
Dynamic nature of G4s: G4s are not static structures but form and resolve dynamically
Sequence variations: Slight differences in G4-forming sequences can lead to different structures and stabilities
In vitro versus in vivo conditions: Results from purified systems may not reflect cellular environments
For instance, the conventional understanding that G4 formation requires G-repeats forming tetrads has been challenged by genome-wide sequencing suggesting G4 formation at non-canonical sites . These apparent contradictions can often be resolved by considering methodological differences and the complex cellular environment affecting G4 dynamics.
The field of G4 antibody development continues to evolve, with several promising directions:
Structure-specific antibodies: Engineering antibodies with enhanced specificity for particular G4 topologies (parallel, antiparallel, or hybrid)
Conformation-sensitive fluorescent antibodies: Developing antibodies that change fluorescence properties upon G4 binding for live-cell imaging
Nanobody development: Expanding on camelid-derived nanobodies like SG4 that offer high affinity and small size for better cellular penetration
Computational antibody design: Leveraging methods like GearBind, a pretrainable geometric graph neural network, to design antibodies with optimized affinity and specificity
These advances promise to enable more precise G4 characterization, potentially allowing distinction between different G4 conformations in cellular contexts and facilitating live-cell tracking of G4 dynamics.
G4 antibodies are increasingly finding applications in disease-related research:
Cancer biology: G4s are enriched in oncogene promoters, and aberrant G4 regulation may contribute to oncogenesis
Neurodegenerative disorders: G4 formation in genes associated with neurodegeneration may affect their expression
Viral infections: Viral genomes can form G4s that regulate viral replication
Genetic diseases: Inherited disorders involving G4-related mechanisms can be studied using G4 antibodies
Drug development: G4 antibodies can help identify and characterize G4-targeting therapeutic compounds
The ability to precisely detect and characterize G4 structures using antibodies like BG4 provides valuable tools for understanding disease mechanisms and developing potential therapeutic strategies targeting G4-related pathways.